BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18187211)

  • 1. Functional neuroimaging in schizophrenia: diagnosis and drug discovery.
    McGuire P; Howes OD; Stone J; Fusar-Poli P
    Trends Pharmacol Sci; 2008 Feb; 29(2):91-8. PubMed ID: 18187211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Background and findings of neuroimaging in schizophrenia: an update].
    Cuevas-Esteban J; Campayo A; Gutiérrez-Galve L; Gracia-García P; López-Antón R
    Rev Neurol; 2011 Jan; 52(1):27-36. PubMed ID: 21246491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuroimaging in schizophrenia].
    Lanzenberger R; Kasper S
    Fortschr Neurol Psychiatr; 2005 Nov; 73 Suppl 1():S51-9. PubMed ID: 16270245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical and physiologic brain imaging in schizophrenia.
    McClure RJ; Keshavan MS; Pettegrew JW
    Psychiatr Clin North Am; 1998 Mar; 21(1):93-122. PubMed ID: 9551493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging in psychiatry: An update.
    Abou-Saleh MT
    J Psychosom Res; 2006 Sep; 61(3):289-93. PubMed ID: 16938503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.
    Howes OD; Egerton A; Allan V; McGuire P; Stokes P; Kapur S
    Curr Pharm Des; 2009; 15(22):2550-9. PubMed ID: 19689327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of antipsychotic treatment on cerebral structure and function in schizophrenia.
    Vita A; De Peri L
    Int Rev Psychiatry; 2007 Aug; 19(4):429-36. PubMed ID: 17671875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia.
    Stone JM
    Curr Pharm Des; 2009; 15(22):2594-602. PubMed ID: 19689330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The glutamate hypothesis of schizophrenia: neuroimaging and drug development.
    Egerton A; Stone JM
    Curr Pharm Biotechnol; 2012 Jun; 13(8):1500-12. PubMed ID: 22283750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging drug action in schizophrenia: research update.
    Laruelle M; Abi-Dargham A
    Eur Psychiatry; 2003 Dec; 18 Suppl 2():32s-37s. PubMed ID: 23570194
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuropsychiatric update: neuroimaging schizophrenia.
    Kile SJ
    Psychopharmacol Bull; 2007; 40(4):156-67. PubMed ID: 18227785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional neuroimaging of hallucinations in schizophrenia: toward an integration of bottom-up and top-down approaches.
    Silbersweig D; Stern E
    Mol Psychiatry; 1996 Nov; 1(5):367-75. PubMed ID: 9154229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging the Nonmotor Symptoms in Parkinson's Disease.
    Yousaf T; Wilson H; Politis M
    Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia.
    Davis CE; Jeste DV; Eyler LT
    Schizophr Res; 2005 Oct; 78(1):45-60. PubMed ID: 15979287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Novel neuroimaging perspectives in the diagnosis of dementia].
    Jessen F
    Nervenarzt; 2008 Nov; 79 Suppl 3():129-36; quiz 137. PubMed ID: 18830576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic drug action: targets for drug discovery with neurochemical imaging.
    Stone JM; Pilowsky LS
    Expert Rev Neurother; 2006 Jan; 6(1):57-64. PubMed ID: 16466312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid progress in neuroimaging technologies fuels central nervous system translational medicine.
    Kong L; He Q; Li Q; Schreiber R; Kaitin KI; Shao L
    Drug Discov Today; 2023 Mar; 28(3):103485. PubMed ID: 36623797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging as tool to investigate psychoses and antipsychotics.
    Booij J; van Amelsvoort T
    Handb Exp Pharmacol; 2012; (212):299-337. PubMed ID: 23129337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroreceptor imaging in psychiatric disorders.
    Frankle WG; Laruelle M
    Ann Nucl Med; 2002 Nov; 16(7):437-46. PubMed ID: 12508833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.
    Erritzoe D; Talbot P; Frankle WG; Abi-Dargham A
    Neuroimaging Clin N Am; 2003 Nov; 13(4):817-32. PubMed ID: 15024964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.